Mounjaro®
Starting from £179.99/mo
Start journey Learn moreCold feet while taking Mounjaro is a recognised pattern that patients report, and it almost always comes down to one of two things: the body-temperature changes that accompany rapid weight loss, or a temporary shift in circulation as the medicine slows digestion and redirects blood flow. These are usually benign and settle with time. That said, persistently cold or numb feet deserve a conversation with your prescriber, because a small number of cases do warrant further investigation. Mounjaro (tirzepatide) is a prescription-only medicine, and any new or concerning symptom should be discussed with the clinician overseeing your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you lose a meaningful amount of body fat over weeks or months, your body has less insulating tissue around blood vessels. Fat acts as a thermal buffer, and as it reduces, extremities like the feet and hands are the first to feel the chill. This is one of the most common explanations for cold feet during Mounjaro treatment, and it tends to become noticeable as weight loss accelerates through the middle titration doses.
There is a second mechanism worth understanding. Tirzepatide activates both GLP-1 and GIP receptors, which slows gastric emptying and triggers a significant shift in blood-flow priorities after injection. In the hours following a weekly dose, the body is managing digestion differently, and peripheral circulation can quietly dial back during that window. Some people find their feet feel coldest in the day or two after their injection, then ease off as the week progresses.
Neither of these mechanisms is dangerous on its own. The NHS tirzepatide medicines page lists the recognised side effects of Mounjaro, and simple cold extremities are not among the serious ones. Fatigue, nausea, and digestive changes are the headline effects; feeling a little colder than usual is a background companion that most people stop noticing once their body has adjusted to the new weight and the medicine's rhythm. More detail on how tirzepatide works is covered on the tirzepatide overview page.
Not quite, though they often overlap. The broader experience of feeling cold on Mounjaro is well documented in patient reports and tends to be whole-body: a lower baseline temperature, needing an extra layer, feeling the draught more than usual. Cold feet can be part of that pattern, but it can also occur on its own.
When coldness is confined mainly to the feet, it is worth considering whether anything else accompanies it. Plain cold skin that warms up with a pair of socks is reassuring. Numbness, pins and needles, a persistent pallor or blue tinge, or feet that stay cold regardless of warmth are different signals. Those warrant a call to your prescriber rather than a wait-and-see approach. People who had any pre-existing circulatory issues before starting Mounjaro should mention foot coldness early rather than later.
A practical habit some patients find helpful: check your feet in the evening when you take off your shoes. If they warm up quickly, the cause is almost certainly the weight-loss mechanism above. If they stay cold or feel numb to touch, log it and contact your clinical team. You can also read the broader picture of feeling cold on Mounjaro to see how foot symptoms fit into the wider pattern.
In most cases, no. But there are specific presentations that move this from a background nuisance into something a prescriber needs to know about promptly.
Peripheral arterial disease, Raynaud's phenomenon, and diabetic peripheral neuropathy all affect circulation or sensation in the feet, and people with any of these conditions may find their symptoms change while on a medicine that alters blood-flow dynamics. If you were already managing one of these conditions before starting Mounjaro, your prescriber will have taken it into account, but new or worsening symptoms still warrant a review.
Dehydration is another factor worth flagging. GLP-1-based medicines reduce appetite significantly, and some people unintentionally eat and drink less than their body needs during the first weeks of treatment. Poor hydration reduces blood volume and can worsen peripheral coldness. Keeping a water bottle within reach, the same way you keep your Mounjaro pen in the fridge door as part of your weekly routine, is a simple step that supports circulation as your body adapts.
The MHRA's Yellow Card scheme exists precisely for symptoms like this: if you suspect a side effect from Mounjaro that concerns you, you can report it via the Yellow Card service, which helps regulators build a complete picture of how medicines behave in practice. There is also a dedicated page covering whether Mounjaro can cause cold feet if you want a more clinical framing of this question.
Start by being specific about what you are experiencing. Simple coldness that responds to warmth is almost certainly related to reduced insulation from weight loss or a post-injection circulation shift. Numbness, tingling, discolouration, or cold feet that do not warm up need a prescriber conversation, not a search engine.
Practically, keeping protein intake adequate helps preserve muscle and circulatory function as fat is lost. Gentle movement helps too: even a short walk keeps peripheral blood moving. If you are taking Mounjaro privately, your clinical team should be available for exactly these questions. A good aftercare service is not just about dose reviews; it is the place where symptoms like cold feet get triaged properly.
If you are exploring treatment or want to understand the full picture of what Mounjaro involves before starting, the Mounjaro information page covers the medicine in detail. For a comparison of costs involved in private treatment, the Mounjaro price comparison guide is a useful reference. And if cold feet is part of a wider symptom picture, the page on feeling cold on Mounjaro generally may help you work out what is driving it. When you are ready to speak to a prescriber, check your eligibility for treatment and our clinical team will review your full picture the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.